Page last updated: 2024-12-11

bombesin (6-13), phe(6) methyl ester-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bombesin (6-13), Phe(6) methyl ester-: bombesin antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5748218
MeSH IDM0193287

Synonyms (11)

Synonym
6-phe-bombesin (6-13) methyl ester
bombesin (6-13), phenylalanine(6) methyl ester-
6-bme
1-de(5-oxo-l-proline)-2-de-l-valine-3-d-phenylalanine-10-l-leucine-11-de-l-methioninamideranatensin methyl ester
(d-phe(6))bn(6-13)methyl ester
bombesin (6-13), phe(6) methyl ester-
ranatensin, 1-de(5-oxo-l-proline)-2-de-l-valine-3-d-phenylalanine-10-l-leucine-11-de-l-methioninamide-, methyl ester
d-phe(6)-bn(6-13)ome
130800-38-3
(6-phe)bn (6-13) methyl ester
methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-5-oxopentanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-3-(4h-imidazol-4-yl)propanoyl]amino
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (90.91)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]